PHLDA1 and familial pancreatic carcinoma: Therefore, targeting PHLDA1 might not only disrupt the detrimental crosstalk between CAFs and tumor cells but also enhance the efficacy of conventional therapies, offering a promising new avenue for pancreatic cancer treatment.